Glycanostics to get €2m from EIC Accelerator

Slovak biotech firm Glycanostics (Ján Tkáč and Tomáš Bertók) landed a €2m grant from the European Innovation Council. It is among the 65 supported companies from 4,000 applicants in the EU-wide EIC Accelerator. It will use the money to complete and patent its cancer tests. It raised €1m via the Crowdberry investment platform in September.

(forbes.sk)